Albany, NY, United States of America

John Frederick Quinn

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 221(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):

Title: **Innovator Spotlight: John Frederick Quinn in Albany, NY**

Introduction

John Frederick Quinn is a prominent inventor based in Albany, NY, who has made significant contributions to the field of pharmaceuticals through his innovative work. With a portfolio that includes 22 patents, Quinn has focused on the development of compounds that play a crucial role in therapeutic applications.

Latest Patents

Quinn's latest patents reflect his expertise in the field of medicinal chemistry, particularly in the area of bromodomain inhibition. His notable inventions include:

1. **Bicyclic bromodomain inhibitors** - This invention pertains to substituted bicyclic compounds that effectively inhibit BET protein function by binding to bromodomains. It also includes pharmaceutical compositions that consist of these compounds and their therapeutic uses.

2. **Substituted bicyclic compounds as bromodomain inhibitors** - Similar to his previous patent, this invention also focuses on substituted bicyclic compounds that inhibit BET protein function and highlights the pharmaceutical applications of these compounds in therapy.

Career Highlights

Throughout his career, John Frederick Quinn has been associated with leading companies in the pharmaceutical sector, including Zenith Epigenetics Corporation and Takeda Pharmaceutical Company Limited. His work has not only advanced the understanding of bromodomain inhibition but also contributed to the development of effective therapeutic agents in various medical fields.

Collaborations

Quinn has collaborated with several talented professionals, including Bryan Cordell Duffy and Shuang Liu. These partnerships have fostered a productive environment for research and innovation, further enhancing the impact of his work in the pharmaceutical industry.

Conclusion

John Frederick Quinn exemplifies the spirit of innovation through his dedication to developing new pharmaceutical solutions. His contributions, particularly in the area of bromodomain inhibitors, have the potential to revolutionize therapeutic practices, ultimately improving patient outcomes and advancing the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…